FDA Warning Letter — Enprani Co., Ltd.
The FDA took a Warning Letter action against Enprani Co., Ltd. on August 15, 2019 (Jung, South Korea). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Enprani Co., Ltd.
- Date
- August 15, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Jung (South Korea)